Delivery Order SPE2DB22D3004-SPE2DB23FQS73
Award Date 7/14/23
Potential Completion Date 7/17/23
Potential Value $958
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $16,007.47 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 2, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors, valued at $1,041.42. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $183,590 firm fixed price delivery order to Amerisourcebergen Drug Corporation for REPATHA 420 MG/3.5ML PUSHTRONX prefilled syringes. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The order is valued at one hundred eighty-three thousand five hundred ninety dollars and will provide the specified pharmaceutical product to the DLA between August 16-17, 2023. No additional details were provided regarding...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,214.99 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to lower cholesterol levels and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,524.96 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 27, 2025. This competitively awarded, firm fixed-price contract was issued on October 24, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with a ceiling value of $1,041.42. This competitively awarded, firm fixed-price delivery order was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to treat high cholesterol and reduce...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $53,634.27 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed-price, competitively awarded delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a $13,332.43 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors on January 12, 2026, with completion expected by January 13, 2026. This firm fixed-price delivery order represents a non-competitive award under an existing contract vehicle and will be performed at the contractor's facility in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to treat high cholesterol and reduce cardiovascular...
- The Defense Logistics Agency awarded a delivery order valued at $14,080.56 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with a completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, PA. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $4,743.33 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 MG/ML SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was executed on January 30, 2026, with an ultimate completion date of February 2, 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB23FQS73Delivery Order
The Defense Logistics Agency awarded a $958 delivery order to Amerisourcebergen Drug Corporation for REPATHA 420 MG/3.5ML PUSHTRONX injectors. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania by July 17, 2023 in support of DLA programs. Amerisourcebergen will serve as the prime contractor to supply the injectable drug used to treat high cholesterol and cardiovascular disease. No subcontractors or set aside designations were indicated. The order was issued against an unspecified DLA-wide contract vehicle and will provide needed pharmaceuticals in the mid-Atlantic region over the short performance period outlined.
Generated 12/17/23, 9:40 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $958 | 7/14/23 |